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Practice Patterns in the Perioperative Treatment
of Patients Undergoing Septorhinoplasty
A Survey of Facial Plastic Surgeons
Scott Shadfar, MD; Allison M. Deal, MS; Andrea M. Jarchow, MD; Hojin Yang, MS; William W. Shockley, MD
IMPORTANCE The common practices used in the perioperative care of patients undergoing
septorhinoplasty are diverse and controversial. A consensus statement on the preferred
clinical pathway in the perioperative treatment of patients undergoing septorhinoplasty has
yet to be approached formally.
OBJECTIVES To investigate the perioperative treatment of patients undergoing
septorhinoplasty and to identify common practice patterns based on the preferences of
leading facial plastic surgeons.
DESIGN, SETTING, AND PARTICIPANTS We distributed an online survey to members of the
American Academy of Facial Plastic and Reconstructive Surgery. Specifically, fellowship
directors and academic contact members were anonymously polled and stratified by the
number of septorhinoplasties performed annually.
MAIN OUTCOME AND MEASURE A cohesive clinical guide to perioperative treatment after
rhinoplasty.
RESULTS Of the 92 members surveyed, 67 (73%) successfully completed the survey. The
distribution of respondents included 43 academicians (64%) and 24 physicians in private
practice (36%). Twenty-eight surgeons (42%) performed fewer than 50 rhinoplasties a year
and 39 (58%), more than 50, representing 3510 to 4549 septorhinoplasties in total among
respondents. Forty-four surgeons (66%) refrained from using any packing, and 41 (61%) used
intranasal splints, with polymeric silicone splints the most popular of these (n = 24 [59%]).
Sixty-six surgeons (99%) used external nasal splints, including 49 (74%) who used a
thermoplastic splint and 49 (74%) who left the external nasal splint in place for 7 days or
longer. The most common postoperative interventions to reduce edema and ecchymosis
were elevation of the head of bed by 62 (93%), ice packs by 50 (75%), and Arnica montana
by 33 (49%). Only 12 surgeons (18%) used postoperative corticosteroids to reduce edema.
Fifty-six respondents (84%) prohibited participation in contact sports until at least 6 weeks
after surgery.
CONCLUSIONS AND RELEVANCE Perioperative care and practices after nasal surgery vary
among the most highly trained and leading rhinoplasty surgeons. No published
communication or consensus on perioperative practices has been disseminated in this
setting. Given the results from those surgeons performing the most rhinoplasties in our field,
some surgeons may choose to vary their practices to coincide with those of experienced
surgeons. These guidelines could facilitate future studies of patient outcomes.
LEVEL OF EVIDENCE NA
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I n 2011, the American Academy of Facial Plastic and Recon-structive Surgery (AAFPRS) conducted a membership sur-vey that revealed rhinoplasty as the most common facial
plastic surgical procedure performed, with a mean of 53 rhi-
noplasties performed by each surgeon.1 In addition, the sur-
vey elucidated the various backgrounds in surgeon training,
demonstrating that members of the AAFPRS and the Ameri-
can Board of Otolaryngology all perform this procedure. The
common practices used in the perioperative care of patients
undergoing septorhinoplasty are diverse and controversial.
Most conventional techniques, such as packing, taping, or
splinting, are variable when comparing surgeons in different
practice settings (eg, academic, private practice, fellowship
trained), even among otolaryngology-trained surgeons. Sev-
eral authors have examined the use of nasal packing, taping,
and splinting in septal and nasal surgery, often revealing con-
flicting outcomes and recommendations.2-6
Kelley et al7 conducted a survey of aesthetic surgeons to
evaluate packing and postoperative rhinoplasty manage-
ment. Their analysis revealed that packing was more com-
mon in a private practice setting, with a drop-off in packing
tendencies as case volume increased. Limitations in their study
included an 8% survey response rate and the fact that only 8%
of respondents were trained in otolaryngology.
A consensus statement on the preferred clinical pathway
in the perioperative treatment of patients undergoing septo-
rhinoplasty has not been formally approached. Previous au-
thors have commented on their specific individualized prac-
tices, which has yielded noteworthy information with regard
to the postoperative management of rhinoplasty. However, no
survey to date has specifically addressed perioperative man-
agement by facial plastic surgeons. This report describes the
results of a survey sent to facial plastic surgeons across North
America inquiring about preferences in the perioperative treat-
ment of patients undergoing septorhinoplasty, with the aim
of developing a formal cohesive clinical pathway to guide all
surgeons interested in rhinoplasty from novice to expert.
Methods
In January of 2012, fellowship directors and academic contact
members within the AAFPRS were sent an online survey (Qual-
trics Laboratories Inc) regarding practice patterns in the peri-
operative treatment of patients undergoing septorhinoplasty.
Of the 92 members initially contacted, 67 (73%) ultimately re-
sponded and completed the survey in its entirety. No respon-
dents returned partially completed measures or dropped out,
and all answers were kept anonymous. The complete survey is
provided in the Supplement (eAppendix). Internal review board
approval was not necessary because the study carried mini-
mal risk and is considered exempt. Informed consent was im-
plied by respondents choosing to participate in the survey.
Respondents were asked to classify their practice type as
private, academic, military, or other. Three respondents an-
swered “other,” and their practices were each coded as aca-
demic given their written response of academic and private.
Respondents were asked to classify the number of primary or
secondary septorhinoplasties they performed in the last 12
months as 0 to 10, 11 to 30, 31 to 50, 51 to 75, 76 to 100, and more
than 100. (For the sake of simplicity, the terms rhinoplasty and
septorhinoplasty will be used interchangeably throughout.) Sur-
geons were then asked about the use of intranasal splints, with
choices regarding the type and length of use and whether they
routinely used splints. Options for write-in responses were
given if “other” was chosen. Similar questions were posed re-
garding packing after septorhinoplasty and use of external na-
sal splints. Several choices about the type and length of use
were given, along with an option for write-in responses un-
der “other.” Surgeons were also asked about the use of perma-
nent suture if an external incision was made and, if used, the
length of time before sutures were removed. Postoperative
wound care was questioned in regard to the materials and types
of ointments and the use of nasal saline. Questions regarding
the use of nasal compression exercises were also posed.
Multiple-choice questions were also provided within the
survey regarding preoperative and postoperative adjuncts
aimed to reduce ecchymosis or edema. More than 1 choice
could be selected, and each intervention was analyzed sepa-
rately. Other practices surveyed included restrictions on the
patient’s physical activities. These activities included their rou-
tine daily activity, manual labor, office work, strenuous exer-
cise, and contact sports. Other questions specifically focused
on restrictions related to wearing eyeglasses, resuming a regu-
lar diet, and nose blowing.
All descriptive calculations and statistical analyses were
performed using commercially available software (SAS, ver-
sion 9.2; SAS Institute Inc). The frequency of each response was
reported and broken down within categories as appropriate.
As described above, AAFPRS membership survey results
showed respondents performed a mean of 53 rhinoplasties per
year.1 We designated those surgeons performing more than 50
rhinoplasties annually as a distinct group performing at a level
above the mean. We will refer to this group as the most expe-
rienced surgeons in terms of case volume (ie, the high-
volume group). This designation serves as a demarcation for
comparison. We used Fisher exact tests to determine whether
responses differed significantly between surgeons perform-
ing more than or fewer than 50 rhinoplasties in the past year.
Results
Of the 92 members surveyed, 67 (73%) successfully com-
pleted the survey. The distribution of respondents included
43 academicians (64%) and 24 physicians classifying them-
selves as surgeons in private practice (36%) (Table 1). The re-
sponses were then stratified by the number of rhinoplasties
performed, with 28 surgeons (42%) performing fewer than 50
rhinoplasties in a year, and 39 (58%) performing more than 50.
Surgeons in private practice were more likely than academic
surgeons to perform more than 50 rhinoplasties a year (75%
vs 49% [P = .04]) (Table 1). These results represent 3510 to 4549
septorhinoplasties among those who completed the survey.
The survey revealed that 44 surgeons (66%) refrained from
using any packing (Table 2). Among the 23 surgeons who used
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packing, nonadherent film dressing (Telfa; Covidien) was the
most commonly used material (12 surgeons [52%]). Forty-
one surgeons surveyed (61%) used intranasal splints, with 24
of these (59%) using splints with polymeric silicone material
(Silastic; Dow Corning). Length of intranasal splinting was not
posed as a question. Only 1 surgeon did not use external nasal
splints. Of the 66 (99%) using an external nasal splint, 49 (74%)
used a thermoplastic splint and 49 (74%) maintained the ex-
ternal nasal splint in place for 7 days or more (Table 2).
Less than half of the surgeons (27 [40%]) reported using pre-
operative adjuncts. The most common type was Arnica mon-
tana, with 23 of the 27 surgeons (85%) advocating its use
(Figure 1A). The use or type of preoperative adjunct did not dif-
fer significantly based on the number of rhinoplasties per-
formed (all P > .20). Only 6 surgeons (9% of all surgeons and 22%
of those who use preoperative adjuncts) prescribe preopera-
tive corticosteroids. The most common postoperative interven-
tions were elevation of the head of bed (62 respondents [93%]),
ice packs (50 [75%]), and prescription of A montana (33 [49%])
(Figure 1B). Surgeons in the high-volume group were almost
twice as likely (24 [61%] vs 9 [32%]) to prescribe A montana post-
operatively compared with surgeons performing fewer than 50
rhinoplasties per year (P = .02) (Figure 1B). Fifty-five surgeons
(82%) did not prescribe postoperative corticosteroids.
Forty-three surgeons (64%) used permanent sutures for
closure of external incisions, and 34 (79%) removed them
on postoperative day 6 or 7. Wound care included the use of
antibiotic ointment by 52 surgeons (78%), hydrogen perox-
ide by 44 (66%), and saline by 40 (60%) (Figure 2). For
improved nasal hygiene, 62 surgeons (93%) advocated nasal
saline sprays. Of the surgeons who suggested the use of
nasal saline, 52 (84%) implemented its use within 3 days.
Saline sprays were used for a minimum of 2 weeks by 60 of
the 62 surgeons (97%), with 23 (37%) recommending it for
longer than 4 weeks.
Nasal compression exercises were recommended by only
22 surgeons (33%). Among the high-volume surgeons, 16 (41%)
advised the use of compression exercises, which did not reach
statistical significance. Of those surgeons recommending na-
sal compression exercises, 12 (55%) agreed on 3 to 6 sessions
per day, and 11 (50%) suggested 1 to 5 minutes per session. Sev-
enteen (77%) waited until after the first postoperative week to
implement the exercises.
Restrictions on wearing eyeglasses and postoperative nose
blowing were placed by 52 (78%) and 60 (90%) surgeons, re-
spectively. The timeline in allowing eyeglass wear varied greatly.
Twelve of the high-volume surgeons (31%) allowed resump-
tion of eyewear at 3 to 4 weeks, whereas 38 of all surgeons (73%)
allowed wear after 3 weeks or longer. Similarly, resumption of
nose blowing varied, with 32 of those surgeons (53%) placing
restrictions of allowing nose blowing from 1 to 2 weeks after sur-
gery. Forty-nine of all surgeons (73%) allowed immediate re-
Table 2. Splints and Packing








Use 41 (61) 19 (68) 22 (56)
Do not use 26 (39) 9 (32) 17 (44)
Polymeric silicone splint, any brand 24 (59) 13 (46) 11 (28)
Silastic sheetc 13 (32) 5 (18) 8 (21)
Other, x-ray film, Telfa,d silicone tube 4 (10) 1 (4) 3 (8)
Packing
Do not use 44 (66) 19 (68) 25 (64)
Use 23 (34) 9 (32) 14 (36)
External splintse
Thermoplastic 49 (74) 19 (70) 30 (77)
Aluminum 12 (18) 5 (19) 7 (18)
Plaster cast 4 (6) 3 (11) 1 (3)
Other, tin, and adhesive bandage 1 (2) 0 1 (3)
Duration of splint, d
≥7 49 (74) 19 (70) 30 (77)
<7 17 (26) 8 (30) 9 (23)
a Indicates surgeons who perform
fewer than 50 rhinoplasties
annually.
b Indicates surgeons who perform
more than 50 rhinoplasties
annually.
c Indicates polymeric silicone (Dow
Corning).
d Indicates nonadherent film dressing
(Covidien).
e Totals exclude the 1 surgeon in the











Private 24 (36) 6 (25) 18 (75)
Academic 43 (64) 22 (51) 21 (49)
Overall 67 (100) 28 (42) 39 (58)
a Indicates surgeons who perform
fewer than 50 rhinoplasties
annually.
b Indicates surgeons who perform
more than 50 rhinoplasties
annually.
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sumption of a regular diet as tolerated. A limitation in sun ex-
posure was the most common write-in restriction.
Questions regarding activity level were also analyzed,
with routine daily activities and office work restrictions
implemented for a minimum of 7 days or more by 39 (58%)
and 43 (64%) surgeons, respectively. Manual labor restric-
tions were limited for at least 2 weeks in 60 of all surgeons’
practices (90%), with 47 (70%) limiting strenuous activity
and exercise for at least 3 weeks. Fifty-six respondents
(84%) placed restrictions on returning to contact sports for
at least 6 weeks (Figure 3).
Discussion
Our results highlight the opinions of 67 experienced practicing
facial plastic surgeons, specifically consisting of fellowship di-
rectors and academic contact members of the AAFPRS. For many
topics, a clear consensus on the type of recommendations was
found. However, often no significant difference was seen be-
tween high- and low-volume surgeons. Questions were bro-
ken into categories and will be discussed separately.
Packing and Splints
Controversial topics, such as packing and internal nasal splints,
were addressed with a clear consensus about recommendations.
Most surgeons (66%) did not use packing. This finding corrobo-
rates those of earlier studies performed by Malki et al3 and
Guyuron,6 who highlighted the underwhelming results and the
morbidity associated with postoperative nasal packing. The bias
against formal nasal packing may be directly related to the post-
operative pain, discomfort, and facial edema, the potential for
septal perforation due to pressure necrosis, and the risk of toxic
shock syndrome that has been associated with packing.7-10 More
important, we suppose that most surgeons do not use packing
because they believe that it is unnecessary. Among surgeons who
chose to use packing (34%), nonadherent film dressing was the
most commonly used material (52%). Packing was most com-
monly left in place for no longer than 24 hours, likely to avoid
the morbidities of packing as discussed above. Respondents sug-
gested not only hesitancy regarding intranasal packing but also
an apparent shift to the use of intranasal splints for stability. The
use of internal nasal splints has virtually supplanted the need
for packing. When surgeons chose to use internal splints, the
most commonly used types were polymeric silicone splints, in-
cluding common brands and polymeric silicone sheets.
The use of external nasal splints is routinely accepted and
advocated by many facial plastic surgeons, with multiple meth-
ods described.11-13 Almost all surgeons surveyed said they used
an external nasal splint. The aim of external splints is to preserve
the operative results by allowing redraping of the soft-tissue


























Wound care management is stratified against the number of rhinoplasties
performed by the 67 respondents. High volume indicates more than 50
rhinoplasties; low volume, less than 50.
aIndicates a petrolatum-based ointment (Beiersdorf, Inc).












































Perioperative adjuncts are stratified against the number of rhinoplasties performed by the 67 respondents. High volume indicates more than 50 rhinoplasties; low
volume, less than 50. A, Preoperative adjuncts. B, Postoperative adjuncts.
aP = .02.
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envelope and securely protecting and stabilizing the nasal
framework.14 The use of external nasal splints was found to be
uniformly agreed on, with 99% of those surveyed taking this
measure. External nasal taping was not addressed in the survey.
Perioperative Adjuncts
Herbals
The use of alternative medical therapies has grown substantially
within the facial plastic surgery community in the last 20 years.
Most notably, the perioperative use of herbal therapies such as
A montana (wolfsbane, leopard bane, mountain tobacco) or bro-
melain (pineapple extract [Ananas sativus]) has increased, with
goals of alleviating perioperative ecchymosis and edema and ac-
celerating wound healing, respectively.15,16 Scientific studies sur-
rounding A montana have produced equivocal results. Negative
findings include those of a placebo-controlled study17 investi-
gating the effects of topical A montana on ecchymoses after la-
ser treatment, which revealed no difference from placebo in the
reduction of ecchymoses. Conversely, Seeley et al18 were able
to use computer models to objectively assess perioperative color
changes in patients after rhytidectomy. Those patients taking
perioperative homeopathic A montana exhibited less ecchymo-
sis. In a randomized clinical comparison of dexamethasone and
A montana administered to patients undergoing rhinoplasty,15,19
results showed that both treatments decreased edema when
compared with the placebo. However, neither medication re-
sulted in a significant decrease in ecchymosis.
Prevention and management of perioperative ecchymo-
sis and edema varied among the surveyed groups. Most sur-
geons (40 [60%]) did not prescribe a preoperative adjunct.
However, the most commonly used was A montana, pre-
scribed by 85% of those surgeons using a preoperative ad-
junct. In addition, 16 (41%) of the high-volume surgeons pre-
scribed A montana preoperatively. Bromelain was prescribed
preoperatively by 2 surgeons.
The postoperative use of A montana increased to 61% of the
surgeons in the high-volume group. Although conflicting evi-
dence exists in the literature, limitations in sample size from a
single surgeon may explain the lack of significance in various
studies. Within this survey, prevalence of A montana prescrip-
tion increased among the respondents; in the setting of conflict-
ing indications, validation with a larger sample is necessary.
Common dosing practices were not addressed within this sur-
vey. The most commonly cited regimen of A montana admin-
istration begins on the day of surgery with a 500-mg capsule
taken orally every 8 hours, with continued administration for
the first 3 postoperative days at the same 8-hour interval.18-20
Commonly used measures aimed to reduce ecchymosis
and edema included ice packs (75%) and elevating of the head
of the bed (93%). In addition, 26 of those surgeons in the high-
volume group (67%) were more likely to prescribe 3 or more
adjuncts in the postoperative setting. Perhaps with the greater
operative experience, those surgeons performing more rhino-
plasties annually have applied multiple adjuncts as a defense
against bruising and swelling.
Antibiotics
The use of preoperative antibiotics was not part of the survey
but is briefly discussed here for the sake of completeness. Ran-
domized clinical trials have shown that prophylactic antibi-
otics are effective in preventing surgical wound infections when
administered within 1 hour of incision.21,22 First- or second-
generation cephalosporins are generally used for prophy-
laxis, whereas those patients at risk of colonization with meth-
icillin-resistant Staphylococcus aureus require alternate
preoperative and postoperative prophylaxis.23-25 The use of an-
tibiotics in nasal surgery, however, remains a point of contro-
versy. Despite several studies citing no difference in infection
rates with the use of postoperative prophylactic antibiotics, a
200% increase in the use of perioperative antibiotics in rhino-
plasty has occurred from 1985 to 2000.23,26-29 This trend for
postoperative antibiotic prophylaxis likely originates from the
fear of toxic shock syndrome, the use of intranasal splints, the
clean-contaminated nature of the surgical wound, the in-
creased incidence of methicillin-resistant Staphylococcus au-
reus colonization, and the use of multiple grafts in revision
procedures.14,25
Corticosteroids
The use of perioperative corticosteroids has long been de-
bated, with conflicting data on the efficacy of routine sys-
temic corticosteroid administration in rhinoplasty. The ratio-
nale behind prescribing perioperative corticosteroids stems
from protracted cases of ecchymosis leading to discoloration
of the skin or significant edema altering the ultimate result.
Multiple variables exist when administering corticosteroids,
including timing of the first dose, route of administration, and
duration, all of which have been challenged. These details were
not identified within the survey to maintain simplicity.
Recently, Hatef et al30 evaluated the use of perioperative
corticosteroids for minimizing edema and ecchymosis after rhi-
noplasty using a meta-analysis. Based on results from 4 pro-
spective trials, perioperative corticosteroid use significantly
reduced postoperative edema and ecchymoses of the upper and
lower eyelids at 1 and 7 postoperative days.30 In addition, the






























Activity restrictions are stratified by the number of rhinoplasties performed by
the 67 respondents. High volume indicates more than 50 rhinoplasties;
low volume, less than 50. The most common answer for length of restriction
per designated activity is listed in parentheses.
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investigators were able to show that the ideal times of admin-
istration were preoperatively (preoperative holding or at in-
duction) and a continuing dose for 2 additional days using an
oral dosage schedule.30
Only 9% of surgeons used corticosteroids as a preopera-
tive adjunct in our survey. Twelve surgeons (18%) prescribed
corticosteroids in the postoperative setting, with only 8 of those
high-volume surgeons (21%) initiating therapy with cortico-
steroids postoperatively. Fifty-five of the surgeons surveyed
(82%) did not prescribe corticosteroids. The reluctance to use
perioperative corticosteroids likely stems from conflicting stud-
ies regarding their efficacy and their published risks and
morbidity.31-33 However, based on the results of Hatef et al,30
evidence-based guidelines for perioperative corticosteroid ad-
ministration could be established when no medical contrain-
dication exists. Based on this information, we would leave this
choice to the discretion of the surgeon. Specifically, indica-
tions could include beneficial effects for those patients with
social obligations and the need for more rapid decrease in the
amount of edema.
Sutures
Direct comparisons of suture techniques for open rhino-
plasty have not been investigated. Parell and Becker34 evalu-
ated facial wound closures using permanent (5-0 coated poly-
propylene) or absorbable (5-0 coated irradiated polyglactin 910)
suture material, with no long-term cosmetic differences noted.
Their conclusions were to use absorbable sutures because these
sutures did not have to be removed, which in turn reduced pa-
tient anxiety and discomfort while saving the surgeon time.34
This finding could be further extrapolated to children. Within
our study population, 64% used nonabsorbable sutures and
79% of these surgeons removed them on postoperative day 6
or 7. In addition, 24 of the high-volume surgeons surveyed
(62%) used a nonabsorbable suture to close their transcolu-
mellar incisions. Most surgeons preferred a minimally reac-
tive nonabsorbable suture to reduce conspicuous scarring de-
spite the possible equal cosmetic outcomes of an absorbable
suture.
Wound Care and Nasal Hygiene
More uniformly accepted among those surveyed was the use
of saline (60%), hydrogen peroxide (66%), and antibiotic oint-
ment (78%) for wound care. The low cost and accessibility of
these products lends them to routine postoperative use.
Nasal saline sprays and irrigations have been well stud-
ied in patients undergoing nasal and paranasal sinus surgery,
with clear benefits aimed at reducing inflammatory irritants
and crusting and promoting mucociliary clearance.35,36 These
benefits resonated within our survey, with 93% of providers
advocating for the use of nasal saline sprays, 84% of these sur-
geons advocating that use of nasal sprays should be initiated
immediately or within 24 hours, and 97% of them recommend-
ing a minimum of 2 weeks of use.
Nasal Compression Exercises
A paucity of data exist concerning the beneficial effects of
nasal compression exercises. Twenty-three of the high-volume
group (59%) did not implement the use of compressive exer-
cises. When we included all surgeons surveyed, only 33%
used these exercises in the postoperative period. Of those
who advise their patients to use the exercises, the most
commonly used regimen was 3 to 6 sessions per day, with
less than 5 minutes per session. These exercises were typi-
cally initiated after the first postoperative week. Most of this
group of leading surgeons appeared to find no benefit in
these exercises.
Restrictions
A more cohesive approach was seen when analyzing restric-
tions on postoperative activity. Routine daily activities and of-
fice work restrictions were implemented for a minimum of 7
days in 58% and 64% of those surveyed, respectively. Manual
labor restrictions were imposed until after 2 weeks in 90% of
surgeons’ practices, with 70% limiting strenuous activity and
exercise until after 3 weeks.
No randomized clinical trials exist in reference to postop-
erative activity. However, the potential risk of injury to the nose
leads most surgeons to take justifiably conservative precau-
tions when advising patients. Six weeks or longer was the nec-
essary time frame chosen by 84% of the respondents before
allowing patients to return to contact sports. This time frame
would coincide with much of the wound healing literature
showing tensile strength of surgical wounds achieving 80% to
90% of full strength at the 6- to 8-week mark.37
Other restrictions enforced by surgeons included limita-
tions on wearing eyeglasses and postoperative nose blowing
(78% and 90%, respectively). The timeline in which the sur-
geons restricted their use was variable. Anecdotal encoun-
ters, mainly circulating around emesis leading to disruption
of the surgical field or hematoma formation, led some sur-
geons to restrict postoperative diets. However, resumption of
a regular diet as tolerated was agreed on by 73% of all sur-
geons surveyed.
Study Limitations
Limitations of our study are related to having only 67 sur-
geons respond. However, we believe that this subset of sur-
geons represents a significant segment of the leaders and edu-
cators in facial plastic surgery. The response rate of 73% is
considered exceptional based on commonly published sur-
vey response rates. Given this rate, one can translate these re-
sponses into meaningful conclusions. The paucity of pub-
lished data surrounding perioperative practices does not allow
for a direct comparison against other cohorts. Nasal taping was
an additional topic that was not addressed, but we believe that
taping is extremely important in the postoperative period. We
used 50 rhinoplasties as the delineation point for comparison
knowing that no evidence exists that a high volume corre-
lates with greater expertise or better patient care. We did not
measure outcomes of the patients using the respective sur-
geons’ algorithms, but we anticipated that most of the sur-
geons surveyed would adjust their practice patterns to fit the
most ideal patient outcomes. The population studied allows
us to infer acceptable outcomes without including reports of
complications or outcomes.
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Conclusions
The implications of this study allow us to generate formal
perioperative guidelines for surgeons performing septorhi-
noplasties. Certainly, facial plastic surgeons will encounter a
variety of patients, and their care should be tailored to the
individual. However, we hope that these survey results will
provide a foundation to guide surgeons in the perioperative
care of their patients undergoing septorhinoplasty. Future
studies could be aimed at studying patient outcomes using
these guidelines.
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